根治性膀胱切除术-话题@MedSci

#根治性膀胱切除术#

31篇内容 | 1944人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2223492, encodeId=52bc222349253, content=<a href='/topic/show?id=d08e2e894e7' target=_blank style='color:#2F92EE;'>#健康相关生活质量#</a> <a href='/topic/show?id=2e2399635a4' target=_blank style='color:#2F92EE;'>#非肌层浸润性膀胱癌#</a> <a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=World J Urol：根治性膀胱切除术后长期存活者与健康人群的健康相关生活质量倾向得分匹配分析比较, objectType=article, longId=841389, objectId=e41b841389e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240621/1718948353174_5579292.jpg, objectUrl=/article/show_article.do?id=e41b841389e0, replyNumber=0, likeNumber=70, createdTime=2024-09-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e41b841389e0, moduleTitle=World J Urol：根治性膀胱切除术后长期存活者与健康人群的健康相关生活质量倾向得分匹配分析比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e41b841389e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2165686, encodeId=f5eb216568630, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>是<a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌层浸润性膀胱癌#</a>（MIBC）患者的标准治疗。然而，根治性膀胱切除术有重大<a href='/topic/show?id=1cf64063952' target=_blank style='color:#2F92EE;'>#围手术期#</a><a href='/topic/show?id=0e1a4903251' target=_blank style='color:#2F92EE;'>#并发症#</a>的风险，并可能损害患者的生活质量。为了解决这些问题，最近的指南推荐使用多模式治疗（MTT）的保膀胱策略，通常包括最大限度的<a href='/topic/show?id=142610e29177' target=_blank style='color:#2F92EE;'>#经尿道切除#</a>（TUR）和化学<a href='/topic/show?id=d2ba5e382ac' target=_blank style='color:#2F92EE;'>#放射治疗#</a>（CRT）作为MIBC患者的一个替代选择。, objectTitle=European Radiology:VI-RADS在肌层浸润性膀胱癌多模式治疗中的新用途, objectType=article, longId=798508, objectId=5691e9850871, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301029/1698587725251_1605392.png, objectUrl=/article/show_article.do?id=5691e9850871, replyNumber=0, likeNumber=133, createdTime=2023-10-30, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5691e9850871, moduleTitle=European Radiology:VI-RADS在肌层浸润性膀胱癌多模式治疗中的新用途, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5691e9850871)], followStatus=false, userIsMember=true, type=1, lengthMark=1), GetTopicListResponse(id=1973308, encodeId=1bff19e330831, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Int J Urol：机器人辅助根治性膀胱切除术后并发症的预测因素 , objectType=article, longId=300482, objectId=927530048279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=927530048279, replyNumber=0, likeNumber=101, createdTime=2022-07-23, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=927530048279, moduleTitle=Int J Urol：机器人辅助根治性膀胱切除术后并发症的预测因素 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=927530048279)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973306, encodeId=1c1819e33061e, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Int J Urol：新辅助化疗对机器人辅助根治性膀胱切除术后患者的生存和复发模式的影响, objectType=article, longId=293624, objectId=479e29362442, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=479e29362442, replyNumber=0, likeNumber=102, createdTime=2022-12-05, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=479e29362442, moduleTitle=Int J Urol：新辅助化疗对机器人辅助根治性膀胱切除术后患者的生存和复发模式的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=479e29362442)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973307, encodeId=2bf819e330765, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=J Urol：开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术的早期结果比较, objectType=article, longId=295421, objectId=588c295421c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588c295421c0, replyNumber=0, likeNumber=87, createdTime=2022-05-11, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588c295421c0, moduleTitle=J Urol：开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术的早期结果比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=588c295421c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973310, encodeId=3de319e3310bb, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率, objectType=article, longId=726589, objectId=410de265896f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=410de265896f, replyNumber=0, likeNumber=94, createdTime=2023-01-19, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=410de265896f, moduleTitle=Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=410de265896f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973302, encodeId=130e19e330286, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=World J Urol：根治性膀胱切除术pentafecta的多中心外部验证 , objectType=article, longId=214744, objectId=f8e7214e4446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8e7214e4446, replyNumber=0, likeNumber=147, createdTime=2021-09-08, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8e7214e4446, moduleTitle=World J Urol：根治性膀胱切除术pentafecta的多中心外部验证 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8e7214e4446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973309, encodeId=fb1319e3309d8, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Int J Urol：非肌层浸润性膀胱癌患者的分层是否有助于确定根治性膀胱切除术的适用人群？, objectType=article, longId=301683, objectId=7879301683a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7879301683a0, replyNumber=0, likeNumber=122, createdTime=2022-03-29, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7879301683a0, moduleTitle=Int J Urol：非肌层浸润性膀胱癌患者的分层是否有助于确定根治性膀胱切除术的适用人群？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7879301683a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973305, encodeId=37ed19e3305c0, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=J Urol：非肌层浸润性膀胱癌中，淋巴结切除术是否能够改善根治性膀胱切除术的治疗效果？, objectType=article, longId=220931, objectId=68b0220931cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68b0220931cf, replyNumber=0, likeNumber=90, createdTime=2022-03-06, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68b0220931cf, moduleTitle=J Urol：非肌层浸润性膀胱癌中，淋巴结切除术是否能够改善根治性膀胱切除术的治疗效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68b0220931cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973303, encodeId=3f3319e330374, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=JU：根治性膀胱切除术前的新辅助化疗对哪些病理类型患者有用？, objectType=article, longId=217744, objectId=76e621e744ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76e621e744ff, replyNumber=0, likeNumber=137, createdTime=2021-10-05, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76e621e744ff, moduleTitle=JU：根治性膀胱切除术前的新辅助化疗对哪些病理类型患者有用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76e621e744ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973304, encodeId=976a19e33042b, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol：行根治性膀胱切除术患者的生存质量如何？, objectType=article, longId=219314, objectId=aa7a219314f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa7a219314f1, replyNumber=0, likeNumber=76, createdTime=2022-02-05, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa7a219314f1, moduleTitle=Eur Urol：行根治性膀胱切除术患者的生存质量如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa7a219314f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973301, encodeId=bd5c19e3301c5, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol Focus：开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术中患者报告的健康相关生活质量的比较, objectType=article, longId=209619, objectId=6e5d209619b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e5d209619b4, replyNumber=0, likeNumber=80, createdTime=2022-03-02, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e5d209619b4, moduleTitle=Eur Urol Focus：开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术中患者报告的健康相关生活质量的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e5d209619b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973297, encodeId=7cce19e329712, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Sci Rep：肌肉脂肪浸润是膀胱癌根治性膀胱切除术后的新型预后生物标记 , objectType=article, longId=205418, objectId=b2b72054180a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2b72054180a, replyNumber=0, likeNumber=159, createdTime=2021-08-21, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2b72054180a, moduleTitle=Sci Rep：肌肉脂肪浸润是膀胱癌根治性膀胱切除术后的新型预后生物标记 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2b72054180a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973300, encodeId=302d19e330098, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol Focus：Apixaban用于根治性膀胱切除术后扩大静脉血栓栓塞症预防的初步经验, objectType=article, longId=209298, objectId=815420929815, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815420929815, replyNumber=0, likeNumber=94, createdTime=2021-07-16, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815420929815, moduleTitle=Eur Urol Focus：Apixaban用于根治性膀胱切除术后扩大静脉血栓栓塞症预防的初步经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815420929815)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973299, encodeId=196919e329933, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol Oncol：新辅助Atezolizumab在接受根治性膀胱切除术的肌肉侵袭性膀胱癌患者中的毒性和手术并发症发生率, objectType=article, longId=207866, objectId=29cc20e866f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29cc20e866f0, replyNumber=0, likeNumber=85, createdTime=2021-09-07, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29cc20e866f0, moduleTitle=Eur Urol Oncol：新辅助Atezolizumab在接受根治性膀胱切除术的肌肉侵袭性膀胱癌患者中的毒性和手术并发症发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29cc20e866f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973295, encodeId=2c7819e329552, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=J Urol：机器人根治性膀胱切除术后90天再入院率的时间、模式和预测因素 , objectType=article, longId=202798, objectId=46e3202e982e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46e3202e982e, replyNumber=0, likeNumber=134, createdTime=2021-01-21, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46e3202e982e, moduleTitle=J Urol：机器人根治性膀胱切除术后90天再入院率的时间、模式和预测因素 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46e3202e982e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973298, encodeId=f22c19e3298d7, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol：膀胱癌患者的机器人辅助根治性膀胱切除术与开放性根治性膀胱切除术的比较 , objectType=article, longId=206193, objectId=824b206193b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=824b206193b7, replyNumber=0, likeNumber=91, createdTime=2021-09-09, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=824b206193b7, moduleTitle=Eur Urol：膀胱癌患者的机器人辅助根治性膀胱切除术与开放性根治性膀胱切除术的比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=824b206193b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973296, encodeId=1bbb19e3296f8, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Eur Urol：腹腔镜下根治性膀胱切除术和乙状结肠膀胱重建术的初步经验 , objectType=article, longId=204270, objectId=52cc2042e0b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52cc2042e0b1, replyNumber=0, likeNumber=96, createdTime=2021-04-28, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52cc2042e0b1, moduleTitle=Eur Urol：腹腔镜下根治性膀胱切除术和乙状结肠膀胱重建术的初步经验 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52cc2042e0b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973293, encodeId=9d5819e32937a, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Sci Rep：根治性膀胱切除术后不良心血管事件风险因素分析, objectType=article, longId=181742, objectId=eac1181e42f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eac1181e42f7, replyNumber=0, likeNumber=87, createdTime=2019-10-31, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eac1181e42f7, moduleTitle=Sci Rep：根治性膀胱切除术后不良心血管事件风险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eac1181e42f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1973294, encodeId=712e19e32941a, content=<a href='/topic/show?id=75a16223199' target=_blank style='color:#2F92EE;'>#根治性膀胱切除术#</a>, objectTitle=Sci Rep：鳞状/腺体组织学变异高风险NMIBC的BCG滴注与根治性膀胱切除术比较, objectType=article, longId=182863, objectId=fb5a18286354, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb5a18286354, replyNumber=0, likeNumber=79, createdTime=2020-08-08, rootId=0, userName=12498710m11暂无昵称, userId=f6142500060, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb5a18286354, moduleTitle=Sci Rep：鳞状/腺体组织学变异高风险NMIBC的BCG滴注与根治性膀胱切除术比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb5a18286354)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

根治性膀胱切除术

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#健康相关生活质量# #非肌层浸润性膀胱癌# #根治性膀胱切除术#

World J Urol：根治性膀胱切除术后长期存活者与健康人群的健康相关生活质量倾向得分匹配分析比较

2024-09-01发表于上海

(审核中...)

前往app查看评论内容

全文收起 #根治性膀胱切除术#是#肌层浸润性膀胱癌#（MIBC）患者的标准治疗。然而，根治性膀胱切除术有重大#围手术期##并发症#的风险，并可能损害患者的生活质量。为了解决这些问题，最近的指南推荐使用多模式治疗（MTT）的保膀胱策略，通常包括最大限度的#经尿道切除#（TUR）和化学#放射治疗#（CRT）作为MIBC患者的一个替代选择。

European Radiology:VI-RADS在肌层浸润性膀胱癌多模式治疗中的新用途

2023-10-30发表于上海

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Int J Urol：机器人辅助根治性膀胱切除术后并发症的预测因素

2022-07-23

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Int J Urol：新辅助化疗对机器人辅助根治性膀胱切除术后患者的生存和复发模式的影响

2022-12-05

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

J Urol：开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术的早期结果比较

2022-05-11

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率

2023-01-19

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

World J Urol：根治性膀胱切除术pentafecta的多中心外部验证

2021-09-08

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Int J Urol：非肌层浸润性膀胱癌患者的分层是否有助于确定根治性膀胱切除术的适用人群？

2022-03-29

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

J Urol：非肌层浸润性膀胱癌中，淋巴结切除术是否能够改善根治性膀胱切除术的治疗效果？

2022-03-06

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

JU：根治性膀胱切除术前的新辅助化疗对哪些病理类型患者有用？

2021-10-05

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol：行根治性膀胱切除术患者的生存质量如何？

2022-02-05

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol Focus：开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术中患者报告的健康相关生活质量的比较

2022-03-02

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Sci Rep：肌肉脂肪浸润是膀胱癌根治性膀胱切除术后的新型预后生物标记

2021-08-21

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol Focus：Apixaban用于根治性膀胱切除术后扩大静脉血栓栓塞症预防的初步经验

2021-07-16

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol Oncol：新辅助Atezolizumab在接受根治性膀胱切除术的肌肉侵袭性膀胱癌患者中的毒性和手术并发症发生率

2021-09-07

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

J Urol：机器人根治性膀胱切除术后90天再入院率的时间、模式和预测因素

2021-01-21

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol：膀胱癌患者的机器人辅助根治性膀胱切除术与开放性根治性膀胱切除术的比较

2021-09-09

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Eur Urol：腹腔镜下根治性膀胱切除术和乙状结肠膀胱重建术的初步经验

2021-04-28

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Sci Rep：根治性膀胱切除术后不良心血管事件风险因素分析

2019-10-31

12498710m11暂无昵称 (审核中...)

前往app查看评论内容

#根治性膀胱切除术#

Sci Rep：鳞状/腺体组织学变异高风险NMIBC的BCG滴注与根治性膀胱切除术比较

2020-08-08

科室
- - 订阅+
  - 更多科室
工具
服务